Sandbox/intraabdominal

Community-acquiered infection in pediatric patients   ▸  Single agent   ▸  Combination Mild-to-moderate severity   ▸  Single agent   ▸  Combination High risk or severity   ▸  Single agent   ▸  Combination

Triple therapy ▸ Lansoprazole 30 mg q12h OR ▸ Omeprazole 20 mg q12h OR ▸ Esomeprazole 40 mg q24h OR ▸ Rabeprazole 20 mg q12h PLUS ▸ Clarithromycin 500 mg q12h. PLUS ▸ Amoxicillin 1 g q12h Quadruple therapy ▸ Bismuth subsalicylate 525 mg orally q6h PLUS ▸ Metronidazol 250 mg orally q6h PLUS ▸ Tetracycline 500 mg orally q6h PLUS ▸ Ranitidine 150 mg orally q12h OR ▸ PPI standard dose Triple therapy ▸ Lansoprazole 30 mg q12h OR ▸ Omeprazole 20 mg q12h OR ▸ Esomeprazole 40 mg q24h OR ▸ Rabeprazole 20 mg q12h PLUS ▸ Clarithromycin 500 mg q12h PLUS ▸ Metronidazole 500 mg q12h Sequential therapy First 5 days ▸ Lansoprazole 30 mg q12h OR ▸ Omeprazole 20 mg q12h OR ▸ Esomeprazole 40 mg q24h OR ▸ Rabeprazole 20 mg q12h PLUS ▸ Amoxicillin 1 g q12h Next 5 days ▸ Lansoprazole 30 mg q12h OR ▸ Omeprazole 20 mg q12h OR ▸ Esomeprazole 40 mg q24h OR ▸ Rabeprazole 20 mg q12h PLUS ▸ Clarithromycin 500 mg q12h PLUS ▸ Tinidazol 500 mg q12h Sequential therapy First 7 days ▸ Lansoprazole 30 mg q12h OR ▸ Omeprazole 20 mg q12h OR ▸ Esomeprazole 40 mg q24h OR ▸ Rabeprazole 20 mg q12h PLUS ▸ Amoxicillin 1 g q12h Next 7 days ▸ PPI standard dose PLUS ▸ Amoxicillin 1 g q12h PLUS ▸ Clarithromycin 500 mg q12h PLUS ▸ Metronidazol 500 mg q12h Third line treatment ▸ Rifabutin 150 mg q2h PLUS ▸ Amoxicillin 1 g IV q12h PLUS ▸ Ciprofloxacin 500 mg/kg IV q12h